Literature DB >> 16375834

Influence of cyclodextrin complexation on piroxicam gel formulations.

Mario Jug1, Mira Bećirević-Laćan, Ana Kwokal, Biserka Cetina-Cizmek.   

Abstract

The aim of this work was to evaluate the role of cyclodextrins in topical drug formulations. Solid piroxicam (PX) complexes with beta-cyclodextrin (beta-CD) and randomly methylated beta-cyclodextrin (RAMEB) were prepared by freeze-drying and characterized using differential scanning calorimetry (DSC), X-ray powder diffractometry (XRPD), Fourier transform infrared spectroscopy (FTIR) and near infrared spectroscopy (NIR). A physical mixture of PX and cyclodextrins was characterized by enhanced dissolution properties compared to the dissolution profile of the pure drug due to in situ complex formation. Formation of the PX-cyclodextrin inclusion complex additionally improved the drug dissolution properties. Influence of CDs on drug permeation from the water dispersion and the prepared hydroxypropyl methylcellulose (HPMC) gels was investigated. Permeation of the drug involved three consecutive processes: dissolution of the solid phase, diffusion across the swollen polymer matrix and drug permeation through the membrane. Complexation increased PX diffusion by increasing the amount of diffusible species in the donor phase. Slower drug diffusion through the HPMC matrix was the rate limiting step in the overall diffusion process. Possible interaction between the hydrophilic polymer and cyclodextrin may result in physicochemical changes, especially in a change of rheological parameters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375834

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  6 in total

1.  Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state.

Authors:  Maite Uzqueda; Carmen Martín; Arantza Zornoza; Miguel Sánchez; María Cristina Martínez-Ohárriz; Itziar Vélaz
Journal:  Pharm Res       Date:  2006-05-16       Impact factor: 4.200

2.  Characterization of methyl-beta-cyclodextrin toxicity in NGF-differentiated PC12 cell death.

Authors:  Joel E Ulloth; Frankis G Almaguel; Amelia Padilla; Liming Bu; Jo-Wen Liu; Marino De Leon
Journal:  Neurotoxicology       Date:  2007-01-13       Impact factor: 4.294

3.  Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.

Authors:  Ibrahim A Alsarra; Mahrous O Ahmed; Fars K Alanazi; Kamal Eldin Hussein Eltahir; Abdulmalik M Alsheikh; Steven H Neau
Journal:  Int J Med Sci       Date:  2010-07-05       Impact factor: 3.738

4.  Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †.

Authors:  Valentina Venuti; Vincenza Crupi; Barbara Fazio; Domenico Majolino; Giuseppe Acri; Barbara Testagrossa; Rosanna Stancanelli; Federica De Gaetano; Agnese Gagliardi; Donatella Paolino; Giuseppe Floresta; Venerando Pistarà; Antonio Rescifina; Cinzia A Ventura
Journal:  Biomolecules       Date:  2019-09-25

5.  Synthesis and Evaluation of Finasteride-Loaded HPMC-Based Nanogels for Transdermal Delivery: A Versatile Nanoscopic Platform.

Authors:  Aousaf Ahmad; Mahmood Ahmad; Muhammad Usman Minhas; Muhammad Sarfraz; Muhammad Sohail; Kifayat Ullah Khan; Sana Tanveer; Shakeel Ijaz
Journal:  Biomed Res Int       Date:  2022-07-19       Impact factor: 3.246

6.  Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit® RL 100 Nanoparticles for Ocular Delivery.

Authors:  Soe Yadanar Khin; Hay Man Saung Hnin Soe; Chaisak Chansriniyom; Natapol Pornputtapong; Rathapon Asasutjarit; Thorsteinn Loftsson; Phatsawee Jansook
Journal:  Molecules       Date:  2022-07-25       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.